mRNA profiling and clinical outcomes in human osteosarcoma (biopsies)
收藏官方服务：
资源简介：
mRNA profiling and clinical outcomes in human osteosarcoma (biopsies)
应用场景：
创建时间：
2013-01-22
相关数据集
A multi-component view of the glioma transcriptome identifies unique immune infiltration patterns in primary glioblastomas and patients with inferior prognosis.
Patients diagnosed with glioblastomas continue to have a dismal prognosis, highlighting the need for a better characterization of these tumors in order to identify more efficient therapies. In this st
NIAID Data Ecosystem100
Full-length transcriptome sequencing reveals gene expression signatures in human soft tissue sarcomas. Full-length transcriptome sequencing reveals gene expression signatures in human soft tissue sarcomas
Soft tissue sarcomas (STSs) are heterogeneous malignancies derived from mesenchymal cells. Due to its rarity, heterogeneity, and limited overall response to chemotherapy, STSs represents a therapeutic
NIAID Data Ecosystem70
Expression data from prostate cancer samples. Homo sapiens
Although many genes have been proposed to be involved in prostate carcinogenesis, no single gene or gene profile has shown to have prognostic value. The main challenge for clinical management is to di
NIAID Data Ecosystem30
Identification of Anticarin-Ã target gene expression in human osteosarcoma cells
To gain insight into the Anticarin-Ã target gene profile in osteosarcoma cells, we performed RNA-seq analysis in MG63 cells upon CCT4 siRNA-mediated knockdown (siCCT4) or Anticarin-Ã. Overall desi
NIAID Data Ecosystem70
Transcriptome analysis of osteosarcoma cell lines treated with FDA-approved drugs
In order to understand the effect of FDA-approved drugs including doxorubicin (DOX) and HDACs inhibitors (PXD101 and PCI-24781) on osteosarcoma, 143B osteosarcoma cells were treated with the single ag
NIAID Data Ecosystem40
